Mirum Pharmaceuticals Inc

NASDAQ:MIRM   3:58:57 PM EDT
23.44
+1.19 (+5.35%)
Earnings Announcements

Mirum Pharmaceuticals Reports Q3 Loss Per Share $0.86

Published: 11/12/2020 14:16 GMT
Mirum Pharmaceuticals, Inc. (MIRM) - Q3 Loss per Share $0.86.
Q3 Earnings per Share Estimate $-0.98 -- Refinitiv Ibes Data (analyst estimates).
As of September 30, 2020, Mirum Had Cash, Cash Equivalents and Investments of $133.7 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.91

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.97

More details on our Analysts Page.